Biosante Pharmaceuticals shares owned by Marathon Capital Management
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Marathon Capital Management
from 13F filings
Historical chart of Marathon Capital Management investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Marathon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Marathon Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $4.5M | 70k | 63.68 |
| 2024-03-31 | $4.9M | 71k | 69.13 |
| 2023-12-31 | $3.8M | 70k | 55.14 |
| 2023-09-30 | $4.2M | 72k | 58.06 |
| 2023-06-30 | $3.7M | 69k | 53.83 |
| 2023-03-31 | $3.4M | 85k | 39.72 |
| 2022-12-31 | $2.9M | 73k | 40.23 |
| 2022-09-30 | $2.3M | 73k | 32.14 |
| 2022-06-30 | $2.2M | 75k | 29.67 |
| 2022-03-31 | $2.1M | 75k | 28.12 |
| 2021-12-31 | $3.4M | 75k | 46.07 |
| 2021-09-30 | $2.4M | 74k | 32.83 |
More positions owned by Marathon Capital Management
View all positions for Marathon Capital Management